Bank of America’s Bolt Biotherapeutics BOLT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.63K | Buy |
282
+1
| +0.4% | +$6 | ﹤0.01% | 6420 |
|
|
2025
Q1 | $2.25K | Hold |
281
| – | – | ﹤0.01% | 6273 |
|
|
2024
Q4 | $3.01K | Sell |
281
-19
| -6% | -$203 | ﹤0.01% | 6230 |
|
|
2024
Q3 | $3.89K | Buy |
300
+269
| +868% | +$3.49K | ﹤0.01% | 6127 |
|
|
2024
Q2 | $471 | Hold |
31
| – | – | ﹤0.01% | 6477 |
|
|
2024
Q1 | $879 | Hold |
31
| – | – | ﹤0.01% | 6316 |
|
|
2023
Q4 | $703 | Hold |
31
| – | – | ﹤0.01% | 6276 |
|
|
2023
Q3 | $653 | Hold |
31
| – | – | ﹤0.01% | 6359 |
|
|
2023
Q2 | $804 | Sell |
31
-558
| -95% | -$14.5K | ﹤0.01% | 6384 |
|
|
2023
Q1 | $16.4K | Buy |
589
+549
| +1,373% | +$15.3K | ﹤0.01% | 5992 |
|
|
2022
Q4 | $1.04K | Hold |
40
| – | – | ﹤0.01% | 6512 |
|
|
2022
Q3 | $1K | Sell |
40
-261
| -87% | -$6.53K | ﹤0.01% | 6769 |
|
|
2022
Q2 | $13K | Sell |
301
-239
| -44% | -$10.3K | ﹤0.01% | 6491 |
|
|
2022
Q1 | $29K | Sell |
540
-2,406
| -82% | -$129K | ﹤0.01% | 6580 |
|
|
2021
Q4 | $288K | Buy |
2,946
+1,910
| +184% | +$187K | ﹤0.01% | 5472 |
|
|
2021
Q3 | $262K | Buy |
1,036
+521
| +101% | +$132K | ﹤0.01% | 5281 |
|
|
2021
Q2 | $160K | Sell |
515
-409
| -44% | -$127K | ﹤0.01% | 5465 |
|
|
2021
Q1 | $608K | Buy |
+924
| New | +$608K | ﹤0.01% | 4607 |
|